NCT01148407
Unknown
Not Applicable
Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
ConditionsCancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- University of Vermont
- Enrollment
- 30
- Locations
- 1
- Last Updated
- 15 years ago
Overview
Brief Summary
Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with a diagnosis of malignancy
Exclusion Criteria
- •Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107Malignant MesotheliomaNCT00898547Alliance for Clinical Trials in Oncology47
Completed
Not Applicable
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and PaclitaxelLung CancerNCT00900172ECOG-ACRIN Cancer Research Group180
Recruiting
Not Applicable
Platelet RNA profiling to screen for cancer in patients with unprovoked venous thromboembolismvenous thromboembolismthrombosis1002765510014523NL-OMON47931Academisch Medisch Centrum270
Completed
Not Applicable
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing SurgeryThromboembolismUnspecified Adult Solid Tumor, Protocol SpecificNCT00096590National Cancer Institute (NCI)60
Unknown
Not Applicable
Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and ControlsNeoplasmNCT02450175Sinai Hospital of Baltimore50